Gofen & Glossberg’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-150,328
| Closed | -$14.9M | – | 492 |
|
|
2019
Q3 | $14.9M | Sell |
150,328
-24,576
| -14% | -$2.34M | 0.5% | 57 |
|
|
2019
Q2 | $16.2M | Sell |
174,904
-37,812
| -18% | -$3.59M | 0.55% | 52 |
|
|
2019
Q1 | $20.1M | Sell |
212,716
-180,764
| -46% | -$15.8M | 0.71% | 45 |
|
|
2018
Q4 | $25.2M | Sell |
393,480
-12,644
| -3% | -$933K | 1% | 30 |
|
|
2018
Q3 | $36.3M | Sell |
406,124
-2,460
| -0.6% | -$217K | 1.25% | 19 |
|
|
2018
Q2 | $32.5M | Sell |
408,584
-419
| -0.1% | -$34.8K | 1.2% | 19 |
|
|
2018
Q1 | $36.5M | Sell |
409,003
-10,522
| -3% | -$1.01M | 1.37% | 17 |
|
|
2017
Q4 | $43.8M | Sell |
419,525
-5,612
| -1% | -$633K | 1.56% | 14 |
|
|
2017
Q3 | $62M | Sell |
425,137
-2,806
| -0.7% | -$382K | 2.3% | 7 |
|
|
2017
Q2 | $55.6M | Buy |
427,943
+609
| +0.1% | +$74.6K | 2.11% | 7 |
|
|
2017
Q1 | $53.2M | Sell |
427,334
-9,317
| -2% | -$1.11M | 2.08% | 8 |
|
|
2016
Q4 | $50.5M | Sell |
436,651
-4,136
| -0.9% | -$461K | 2.06% | 8 |
|
|
2016
Q3 | $46.1M | Sell |
440,787
-4,901
| -1% | -$530K | 1.91% | 9 |
|
|
2016
Q2 | $44M | Buy |
445,688
+2,963
| +0.7% | +$306K | 1.84% | 9 |
|
|
2016
Q1 | $44.3M | Buy |
442,725
+6,420
| +1% | +$661K | 1.89% | 9 |
|
|
2015
Q4 | $52.3M | Buy |
436,305
+1,848
| +0.4% | +$214K | 2.27% | 7 |
|
|
2015
Q3 | $47M | Sell |
434,457
-6,103
| -1% | -$757K | 2.14% | 5 |
|
|
2015
Q2 | $51M | Buy |
440,560
+5,137
| +1% | +$587K | 2.15% | 6 |
|
|
2015
Q1 | $50.2M | Sell |
435,423
-9,649
| -2% | -$1.15M | 2.16% | 7 |
|
|
2014
Q4 | $49.8M | Sell |
445,072
-11,392
| -2% | -$1.2M | 2.14% | 6 |
|
|
2014
Q3 | $43.3M | Sell |
456,464
-6,626
| -1% | -$598K | 1.91% | 10 |
|
|
2014
Q2 | $39.8M | Sell |
463,090
-3,294
| -0.7% | -$250K | 1.76% | 14 |
|
|
2014
Q1 | $37.5M | Sell |
466,384
-6,080
| -1% | -$481K | 1.75% | 13 |
|
|
2013
Q4 | $39.9M | Sell |
472,464
-24,804
| -5% | -$1.96M | 1.87% | 10 |
|
|
2013
Q3 | $38.3M | Sell |
497,268
-24,158
| -5% | -$1.69M | 1.97% | 8 |
|
|
2013
Q2 | $30.5M | Buy |
+521,426
| New | +$31.4M | 1.65% | 14 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Gofen & Glossberg's CELG Position: Q4 2019 in Review
Gofen & Glossberg sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 150,328 shares — an estimated $14.9M sold.
Gofen & Glossberg first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $62M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Gofen & Glossberg reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Gofen & Glossberg sold 150,328 Celgene Corp shares in Q4 2019, an estimated $14.9M.
- Gofen & Glossberg first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Gofen & Glossberg's Celgene Corp position peaked at $62M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Gofen & Glossberg's 13F filing for Q4 2019, filed 28 Jan 2020.